GlassScriptPhysician profile
Steven C Diamond
NPI 1720165947
$884.27
in general payments reported to CMS, 2019-2025
21 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $69.59 · 2021: $225 · 2022: $141 · 2023: $72.79 · 2024: $153 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $290.43 | 2020-2025 | Aptima, Fluent Fluid Management System, Novasure |
| Abbvie INC. | $114.64 | 2021-2025 | |
| Astellas Pharma US INC | $97.62 | 2021-2024 | Veozah |
| Allergan, INC. | $59.76 | 2019 | |
| Pfizer INC. | $41.49 | 2022-2024 | |
| Shield Therapeutics INC | $31.44 | 2024 | |
| Sumitomo Pharma America, INC. | $29.23 | 2025 | Myfembree |
| Innovation Technologies INC | $21.60 | 2020 | |
| Daiichi Sankyo INC. | $19.55 | 2022 | |
| Becton, Dickinson and Company | $18.02 | 2022 | |
| Organon LLC | $17.20 | 2023 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $16.21 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.08 | 2025 | |
| Amgen INC. | $15.71 | 2021 | |
| Ethicon US, LLC | $15.27 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.19 | 2021 | |
| Olympus America INC. | $14.95 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.80 | 2019 | |
| Smith+Nephew, INC. | $12.63 | 2019 | |
| Agile Therapeutics, INC. | $12.38 | 2021 | |
| Minerva Surgical, INC | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Diamond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.